2014-
_________________
2013
Tokunaga, M., Shiheido, H., Hayakawa, I., Utsumi, A., Takashima, H., Doi, N. (corresponding author), Horisawa, K., Sakuma-Yonemura, Y., Tabata, N., Yanagawa, H. Hereditary spastic paraplegia protein spartin is an FK506-binding protein identified by mRNA Display. Chem. Biol. 20, 935-942 (2013)
Tokunaga, M., Shiheido, H., Tabata, N., Sakuma-Yonemura, Y., Takashima, H., Horisawa, K., Doi, N., Yanagawa, H. MIP-2A is a novel target of an anilinoquinazoline derivative for inhibition of tumor cell proliferation. PLoS ONE 8, e76774 (2013)
土居信英, 柳川弘志. 進化分子工学による新規タンパク質の創出とプロテオミクスへの応用.「進化分子工学 ~高速分子進化によるタンパク質・核酸の開発~」(伏見譲編) NTS出版, pp. 275-286 (2013)
2012
Sumida, T., Yanagawa, H., Doi, N. In vitro selection of Fab fragments by mRNA display and gene-linking emulsion PCR. J. Nucleic Acids 2012, 371379 (2012)
Shiheido, H., Naito, Y., Kimura, H., Genma, H., Takashima, H., Tokunaga, M., Ono, T., Hirano, T., Du, W., Yamada, T., Doi, N., Iijima, S., Hattori, Y., Yanagawa, H. An anilinoquinazoline derivative inhibits tumor growth through interaction with hCAP-G2, alpha subunit of condensin II. PLoS ONE 7, e44889 (2012)
Shiheido, H., Terada, F., Tabata, N., Hayakawa, I., Matsumura, N., Takashima, H., Ogawa, Y., Du, W., Yamada, T., Shoji, M., Sugai, T., Doi, N., Iijima, S., Hattori, Y., Yanagawa, H. A phthalimide derivative that inhibits centrosomal clustering is effective on multiple myeloma. PLoS ONE 7, e38878 (2012)
Doi, N. (corresponding author), Yamakawa, N., Matsumoto, H., Yamamoto, Y., Nagano, T., Matsumura, N., Horisawa, K., Yanagawa, H. DNA display selection of peptide ligands for a full-length human G protein-coupled receptor on CHO-K1 cells. PLoS ONE 7, e30084 (2012)
Tanaka, J., Yanagawa, H., Doi, N. Evolutionary Engineering of Artificial Proteins with Limited Sets of Primitive Amino Acids. In: Protein Engineering, Kaumaya, P. (Ed.), pp. 59-74, InTech, Rijeka, Croatia (2012)
土居信英. 無細胞提示系による低分子抗体の試験管内進化.「次世代医薬開発に向けた抗体工学の最前線」シーエムシー出版, pp. 66-73 (2012)
2011
Tanaka, J., Yanagawa, H., Doi, N. Comparison of the frequency of functional SH3 domains with different limited sets of amino acids using mRNA display. PLoS ONE 6, e18034 (2011)
Shiheido, H., Takashima, H., Doi, N. (corresponding author), Yanagawa, H. mRNA display selection of an optimized MDM2-binding peptide that potently inhibits MDM2-p53 interaction. PLoS ONE 6, e17898 (2011)
Doi, N. (corresponding author), Kakukawa, K., Oishi, Y., Yanagawa, H. High Solubility of Random-Sequence Proteins Consisting of Five Kinds of Primitive Amino Acids. In: Chemical Synthetic Biology, Luisi, L. and Chiarabelli, C. (Eds.), pp. 121-137, A John Wiley & Sons, UK (2011)
2010 (IN 堀澤健一;OUT 柳川弘志)
Matsumura, N., Tsuji, T., Sumida, T., Kokubo, M., Onimaru, M., Doi, N., Takashima, H., Miyamoto-Sato, E., Yanagawa, H. mRNA display selection of a high-affinity, Bcl-XL-specific binding peptide. FASEB J. 24, 2201-2210 (2010)
Tanaka, J., Doi, N. (co-corresponding author), Takashima, H., Yanagawa, H. Comparative characterization of random-sequence proteins consisting of 5, 12 and 20 kinds of amino acids. Protein Sci. 19, 786-795 (2010)
Chiku, M., Horisawa, K., Doi, N., Yanagawa, H., Einaga, Y. Electrochemical detection of tyrosine derivatives and protein tyrosine kinase activity using boron-doped diamond electrodes. Biosens. Bioelectron. 26, 235-240 (2010
柳川弘志, 土居信英. 生体高分子の進化工学.「現代生物科学入門9:合成生物学」岩波書店, pp. 1-34 (2010)